Big thinkers to Focus on Innovation in Times of Austerity The Innovation Debate 2012

   Big thinkers to Focus on Innovation in Times of Austerity The Innovation
                                 Debate 2012

  PR Newswire

  CHERTSEY, England, November 15, 2012

CHERTSEY, England, November 15, 2012 /PRNewswire/ --

      The Royal Society ,  20 ^th  November 2012 - to be webcast live

Chaired by PROFESSORJim Al-Khalili with panellists including: Nobel
prize-winning physicist Professor Andre Geim , famous for his ground-breaking
experiments on graphene;  PROFESSORPaul Workman , Deputy Chief executive of
the Institute for Cancer Research; Tudor Brown , co-founder of ARM one of
Britain's most successful technology companies

  *Discussing big themes: innovation in times of austerity and how we nurture
    scientific innovators
  *Generating ideas: how to ensure that innovation is really valued and
    invested in

How do we nurture innovation in times of austerity? Who funds it? Does a lack
of money encourage inventiveness or does it stifle innovation as everyone
plays it safe?  And what about the innovators of the future? Are we doing
enough to nurture and support talent?


In a tough economic climate, innovation cannot be sacrificed. It is the
lifeblood of science, technology and the economy. There is an urgent need to
focus on how best to promote and nurture innovation - today and in the future.

That is why The Innovation Debate 2012 - organised and funded by Astellas
Pharma Europe Ltd .- at the Royal Society on 20 ^th November 2012 is bringing
together influential and respected figures from the worlds of science,
technology, medicine, engineering, education, government, industry and media
to discuss how best to encourage and nurture scientific innovation.

Chaired by physicist, author and broadcaster Professor Jim Al-Khalili , and
with panelists including Nobel prize- winning physicist Professor Andre Geim ;
the co-founder and former president of technology company ARM Tudor Brown and
the Deputy Chief Executive of the Cancer Research Institute Professor Paul
Workman , The Innovation Debate will examine how we can prevent today's
economic and budgetary pressures from jeopardising innovation for current and
future generations.

The aim of The Innovation Debate is to air crucial issues, draw positive
conclusions and to move the agenda forward.

Everyone - professionals in science and technology, students and the general
public - will have the opportunity to engage with The Innovation Debate
through online media which will take discussions far beyond the walls of the
Royal Society.

"The Innovation Debate is a timely event," says Professor Jim Al-Khalili. "The
world of science and technology needs to reclaim the very word 'innovation'.
So how can we encourage innovation in today's age of austerity - and how do we
ensure we have the innovators of the future? We need to consider how we can
maximise the chances of producing innovative ideas from our scientists and
technologists and how we should train the next generation of scientists and

"Like every other field of endeavour, scientific research is under pressure
for funding - but what are the implications of, say, cutting funding for basic
research if its economic or societal benefits are not immediately evident? And
how might innovation suffer as a result? These are the kind of questions we
will be discussing at The Innovation Debate."

Among the subjects for debate on 20 ^th November are: 'How to innovate in a
time of austerity?' and 'How best to nurture innovation?'

Participate in the debate

The Innovation Debate will encourage wider participation from the public and
science community via the website . Everyone will
have the opportunity share their views on the critical challenges facing
science and innovation raised by The Innovation Debate and to submit a
question to the panel of experts. By signing up to view the live webcast of
the Debate, to be streamed from 4pm on November 20 ^th 2012, online
participants can vote on important issues and make their voice heard. 

Join the debate now at and follow us on Twitter
@Innovatedebate #innovationdebate

Notes to editors

The Innovation Debate is be chaired by broadcaster and physicist Professor Jim

Confirmed panelists include:

Professor Paul Boyle  

Chief Executive, Economic and Social Research Council & President of Science

Tudor Brown      

Co-founder and former President of world-leading technology company, ARM

Dr Beau Lotto

Founder of the Lotto Lab, University College London

Professor Andre Geim

Nobel Prize winner in Physics in 2010 "for groundbreaking experiments
regarding the two-dimensional material graphene"

Professor Mariana Mazzucato  

RM Phillips Professor of Science and Technology at the University of Sussex;

Professor Paul Workman     

Deputy Chief Executive, the Institute for Cancer Research

About Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., located in the UK, is the European headquarters
of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company
dedicated to improving the health of people around the world through the
provision of innovative and reliable pharmaceuticals. The organisation's focus
is to deliver outstanding R&D and marketing to continue growing in the world
pharmaceutical market. Astellas Pharma Europe Ltd. is responsible for 21
affiliate offices located across Europe, the Middle East and Africa, an R&D
site and three manufacturing plants. The company employs approximately 4,300
staff across these regions. For more information about Astellas Pharma Europe,
please visit .

Contact: For further information, please contact: Mindy Dooa, Communications
Director, Astellas Pharma Europe Ltd, Tel: +44-(0)203-379-8035 ,
Mobile:+44-(0)7826-912-339 , Email:
Press spacebar to pause and continue. Press esc to stop.